Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids - PubMed (original) (raw)

Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids

P Libby et al. J Clin Invest. 1988 Feb.

Abstract

There is much interest in defining the signals that initiate abnormal proliferation of cells in a variety of states characterized by the presence of mononuclear phagocytes. Since IL-1 is a major secretory product of activated human monocytes we examined whether this cytokine can stimulate the growth of human vascular smooth muscle cells (SMC). Neither recombinant IL-1 (rIL-1) alpha (less than or equal to 5.0 ng/ml) nor beta (less than or equal to 100 ng/ml) stimulated SMC growth during 2-d incubations under usual conditions. IL-1 did stimulate SMC to produce prostanoids such as PGE1 or PGE2 that can inhibit SMC proliferation. When prostaglandin synthesis was inhibited by indomethacin or aspirin both rIL-1 alpha and beta (greater than or equal to 1 ng/ml) markedly increased SMC growth. In longer-term experiments (7-28 d) rIL-1 stimulated the growth of SMC even in the absence of cyclooxygenase inhibitors. The addition of exogenous PGE1 or PGE2 (but not PGF1 alpha, PGF2 alpha, PGI2) to indomethacin-treated SMC blocked their mitogenic response to rIL-1. Antibody to IL-1 (but not to platelet-derived growth factor [PDGF]) abolished the mitogenic response of SMC to rIL-1. Exposure of SMC to rIL-1 or PDGF caused rapid (maximal at 1 h) and transient (baseline by 3 h) expression of the c-fos proto-oncogene, determined by Northern analysis. We conclude that IL-1 is a potent mitogen for human SMC. Endogenous prostanoid production simultaneously induced by IL-1 appears to antagonize this growth-promoting effect in the short term (2 d) but not during more prolonged exposures. IL-1 produced by activated monocytes at sites of tissue inflammation or injury may thus mediate both positive and negative effects on SMC proliferation that are temporally distinct.

PubMed Disclaimer

Cited by

Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells.
Gay CG, Winkles JA. Gay CG, et al. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):296-300. doi: 10.1073/pnas.88.1.296. Proc Natl Acad Sci U S A. 1991. PMID: 1898777 Free PMC article.
Lack of Correlation Between Activation of Hemostatic Mechanism and Inflammation in Unstable Angina Pectoris.
Oltrona L, Merlini PA, Savonitto S, Broccolino M, Giarratana G, Pezzano A, Mannucci PM, Ardissino D. Oltrona L, et al. J Thromb Thrombolysis. 1998 May;5(2):169-173. doi: 10.1023/A:1008890314994. J Thromb Thrombolysis. 1998. PMID: 10767113
Chagas' disease.
Tanowitz HB, Kirchhoff LV, Simon D, Morris SA, Weiss LM, Wittner M. Tanowitz HB, et al. Clin Microbiol Rev. 1992 Oct;5(4):400-19. doi: 10.1128/CMR.5.4.400. Clin Microbiol Rev. 1992. PMID: 1423218 Free PMC article. Review.
Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme.
Geng YJ, Libby P. Geng YJ, et al. Am J Pathol. 1995 Aug;147(2):251-66. Am J Pathol. 1995. PMID: 7639325 Free PMC article.
Heparin and the phenotype of adult human vascular smooth muscle cells.
Sorger T, Friday N, Yang LD, Levine EM. Sorger T, et al. In Vitro Cell Dev Biol Anim. 1995 Oct;31(9):671-83. doi: 10.1007/BF02634088. In Vitro Cell Dev Biol Anim. 1995. PMID: 8564078

References

1. Am J Pathol. 1979 Jun;95(3):775-92 - PubMed
1. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3183-7 - PubMed
1. Am J Pathol. 1987 Jan;126(1):51-60 - PubMed
1. Arteriosclerosis. 1985 Mar-Apr;5(2):186-91 - PubMed
1. Nature. 1984 Dec 20-1985 Jan 2;312(5996):716-20 - PubMed

Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids - PubMed (original) (raw)